| OPENING SPECIAL LECTURE. “Helmut Drexler. In Memoriam” |
| Helmut Drexler. Human and scientific legacy. |
Kai C. Wollert |
|
 |
| Innovation against heart failure. Lessons from Helmut’s contribution and vision. |
Bernard Gersh |
|
|
| WHAT’S NEW IN STEM CELL THERAPY FOR CARDIAC REPAIR? |
| Induced pluripotent cells: the next regenerative platform? |
Andre Terzic |
|
|
| Adult stem cells. Advances and perspectives. |
Felipe Prosper |
|
|
| The paradox of functional benefit despite no regeneration. Is paracrine effect the answer? |
Stefanie Dimmeler |
|
|
| Delivery, homing and survival. Questions and answers. |
Nabil Dib |
|
 |
| Clinical trials in perspective. Are they justified? Which type? |
Robert Simari |
|
|
| SPECIAL THEMED SESSION: INNOVATIONS FOR ADVANCED HEART FAILURE |
| Surgical Therapies for Heart Failure. New developments. |
Magdi Yacoub |
|
|
| The changing face of heart transplantation. |
Hari R. Mallidi |
|
|
| Mechanics for bridge or destination. The German Heart Institute experience. |
Thomas Krabatsch,Roland Hetzer |
|
|
| Optimizing engineered heart tissue for therapeutic applications. |
Wolfram-Hubertus Zimmerman |
|
|
| Cell-based bioartificial heart. What’s new? |
Doris Taylor |
|
|
| SPECIAL LECTURE |
| The future of stem cell therapy research. Advice for young researchers. |
Valentin Fuster |
|
|
| BEST POSTERS PRESENTATION |
| 1. Strategy for nuclear reprogramming affects cardiogenic potential of induced pluripotent stem cells. |
Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A |
|
|
| 2. Transplantation of AD-SVF in a model of chronic MI induces long-term improvement in cardiac function |
M. Mazo, A. Cemborain, JJ Gavira, G. Abizanda, I. Peñuelas, JM. García-Verdugo, B. Pelacho, F. Prósper |
|
|
| 3. The Cardiac Atrial appendage Stem Cell: a true candidate for myocardial repair? |
Severina Windmolders |
|
|
| RECENT CONTRIBUTIONS PRESENTED BY YOUNG RESEARCHERS |
| Pluripotent stem cell-based cardiogenesis and repair. |
Timothy J. Nelson |
|
|
| Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia. |
Jan van Ramshorst |
|
|
| Polish project on very small embryonic-like (VSEL) cells in cardiology. |
Wojtek Wojakowski |
|
|
| Understanding the mechanisms and potential of cell therapy for the repair of the adult mammalian heart. |
Keng Ang |
|
|
| Generation of pig induced pluripotent stem cells: methods, characterization and future implications in human cell therapy. |
Nuria Montserrat |
|
|
| LATE BREAKING CLINICAL TRIALS IN STEM CELL THERAPY |
| First US study to assess the feasibility & safety of endocardial delivery of allogenic mesenchymal cells in subjects with heart failure. |
Nabil Dib |
|
|
| Freshly adipose-derived stem cells in chronic ischaemia. The PRECISE Trial. |
Emerson Perin,Francisco Fernández-Aviles |
|
|
| Freshly adipose-derived stem cells in acute myocardial infartion. The APOLLO Trial. |
Eric Duckers |
|
|
| CLOSING SESSION |
| Next steps in stem cell therapy for heart repair. The preclinical view. |
Bernardo Nadal-Ginard |
|
|
| Next steps in stem cell therapy for heart repair. The clinical view. |
Andreas Zeiher |
|
|
| ADJOURN |
Francisco Fernandez-Aviles |
|
|
